E-Mo Biotech Holding

E-Mo Biotech Holding is a company engaged in vaccine, immunological treatment, and diagnostic product research and development. It conducts clinical trials to repurpose poliomyelitis virus vaccines to prevent infectious diseases, including SARS-COV-2.